Both Retatrutide and Semaglutide represent significant advancements in obesity treatment , but they function through varied mechanisms. Semaglutide primarily impacts GLP-1 receptors, promoting insulin release https://sairaieeg888744.blogunteer.com/40487880/novoretatrutide-vs-wegovy-a-head-to-head-analysis